Meridian Investment Counsel Inc. Has $1.66 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Meridian Investment Counsel Inc. lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 6.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,800 shares of the biotechnology company’s stock after selling 200 shares during the quarter. Meridian Investment Counsel Inc.’s holdings in Axon Enterprise were worth $1,664,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Asset Dedication LLC raised its holdings in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after buying an additional 18 shares in the last quarter. Bleakley Financial Group LLC boosted its position in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after buying an additional 20 shares in the last quarter. Venturi Wealth Management LLC grew its stake in Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after buying an additional 21 shares during the last quarter. Insigneo Advisory Services LLC increased its holdings in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC raised its stake in shares of Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after acquiring an additional 24 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on AXON. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $534.95 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The firm has a fifty day moving average of $589.62 and a two-hundred day moving average of $550.61. The stock has a market capitalization of $40.99 billion, a price-to-earnings ratio of 138.23, a PEG ratio of 5.17 and a beta of 1.12.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.